Migrants’ access to care depends on their health insurance coverage in the host country. We aimed to evaluate in France the dynamic and the determinants of health insurance coverage acquisition among sub-Saharan migrants.
In the PARCOURS life-event retrospective survey conducted in 2012–2013 in health-care facilities in the Paris region, data on health insurance coverage (HIC) each year since arrival in France has been collected among three groups of sub-Saharan migrants recruited in primary care centres (N = 763), centres for HIV care (N = 923) and for chronic hepatitis B care (N = 778). Year to year, the determinants of the acquisition and lapse of HIC were analysed with mixed-effects logistic regression models.
In the year of arrival, 63.4% of women and 55.3% of men obtained HIC. But three years after arrival, still 14% of women and 19% of men had not obtained HIC. HIC acquisition was accelerated in case of HIV or hepatitis B infection, for migrants arrived after 2000, and for women in case of pregnancy and when they were studying. Conversely, it was slowed down in case of lack of a residency permit and lack of financial resources for men. In addition, women and men without residency permits were more likely to have lost HIC when they had one.
Citation: Vignier N, Desgrées du Loû A, Pannetier J, Ravalihasy A, Gosselin A, Lert F, et al. (2018) Access to health insurance coverage among sub-Saharan African migrants living in France: Results of the ANRS-PARCOURS study. PLoS ONE 13(2): e0192916. https://doi.org/10.1371/journal.pone.0192916
Editor: Michael Gusmano, Rutgers School of Public Health, UNITED STATES
Received: May 9, 2017; Accepted: January 20, 2018; Published: February 15, 2018
Copyright: © 2018 Vignier et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files. Any additional queries may be sent to IRD-Paris Descartes, ERL INSERM 1244 SAGESUD coordinator (ADL) at email@example.com.
Funding: This study was supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) and and Santé Publique France and the Directorate-General of Health (DGS, French Ministry of Health). AR was granted by Sante Publique France. The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the article.
Competing interests: The authors have declared that no competing interests exist.
With 244 million international migrants worldwide and increasing migration to Europe, migration is a global phenomenon that could influence the health of individuals [1, 2]. The question of the health of migrants and their access to the health care system is therefore more acute. Despite an increasing focus on migration globally, there are insufficient data on the interaction between migration and health and of how health systems cope with immigration . The migrant population is very heterogeneous, depending on their country of origin, the circumstances of migration and the living condition at arrival in the host country. However, many migrants arriving in Europe from developing countries, and particularly those arriving from Africa, experience difficult migration pathways and find themselves in a precarious situation after arrival in the host countries . They are thus considered at higher risk for a range of health problems in Europe, especially the undocumented ones, which are the most vulnerable [5, 6]. This higher risk is partly due to poor socioeconomic conditions and, in some countries, is due to the lack of rights to health coverage for undocumented migrants [7–9]. Existing evidence from different European countries highlights the difficulties to access health services that migrants are facing [10–13]. These difficulties are due to various reasons as lack of health insurance coverage or insufficient knowledge of rights and structures [14–18]. Access to health insurance that provides coverage for medical and hospital care is a major determinant of healthcare access and reduction of morbidity and mortality [19–22]. Universal health coverage is the subject of a globally approved United Nations General Assembly resolution and is the third Sustainable Development Goal of the UN Development Programme [23, 24]. In addition, the specific challenges encountered in the field of migration and health has been recognized as a priority for research, as the need for better evidence to improve health system responses to migration [3, 25].
In France, the health-care system was built at the end of World War II as part of the social security system and, to date, has continuously improved to ensure health access for all . It is based on a public health insurance system named Health Insurance (HI) (see the supporting information S1 for a detailed description) (S1 Text). HI is based on compulsory social insurance funded by social contributions. Government provides basic Health Insurance Coverage (HIC) for French and foreign people residing in France regularly and working, studying or being linked to a recipient of the social security system (assignee). This Standard health Insurance is supplemented by a voluntary private insurance that covers health care costs not reimbursed. However, such supplementary insurance is less common among the lower segments of the population. In 1999 was created the Universal Health insurance Coverage (UHC) for French people and foreign nationals living legally in France under an income ceiling and who were previously excluded from Health Insurance based on administrative and/or socio-professional criteria. UHC provided them the right to basic health insurance for basic welfare and, depending on income, for complementary health insurance. Thus, UHC is basic health insurance coverage for inactive people living regularly in France without an assignee.
At the same time, the State Medical Assistance (SMA) was created for undocumented immigrants . SMA covers the entire cost of care. Several supporting documents are required to apply: passport or identity card, an address of domiciliation and over three months’ presence in France. Beneficiaries must be below a resource threshold similar to the supplementary UHC coverage threshold (in the order of $ 10,000 annually for a single person). Dependent people can also benefit from State Medical Assistance (i.e. partners and children). In theory, all healthcare professionals are obliged to accept SMA beneficiaries and forbid them from exceeding fee. The period of entitlement is one renewable year. With the SMA, France is one of the few European countries to ensure a wide access to care for undocumented migrants, but through a separate system..
In contrast to these theoretical possibilities of universal access to care, some reports shows that this access to care is not as easy as it should be [20, 26, 29–31]. There is limited empirical research available that analyses migrants’ access to Health Insurance Coverage.
People from sub-Saharan Africa are at a higher risk of HIV and chronic hepatitis B (CHB) infections and need preventive services and access to diagnostic, care and treatment [32, 33]. For migrants living with HIV or CHB, being engaged in care promotes medication adherence, prevents complications, and decreases the risk of transmission [34–36]. Health insurance coverage could play an important role in their diagnosis, entry and retention in care .
Using the data from a large life-event survey of people from sub-Saharan Africa living in France with or without HIV or CHB, we aimed to investigate the acquisition time of Health insurance after arrival in France and how acquisition and disruption are associated with social, administrative and medical determinants.
Study design and participants
The PARCOURS study was conducted to analyse how health trajectories and social and migratory paths are interlaced for migrants from sub-Saharan Africa who are living in France. This retrospective quantitative life-event survey was conducted from February 2012 to May 2013 in health-care facilities in the Paris metropolitan area (Ile-de-France). Three groups of migrants born in sub-Saharan Africa have been studied: one group followed in care for HIV infection in dedicated HIV centres (HIV group), one group in care for Chronic Hepatitis B (without concomitant HIV infection) followed in dedicated CHB centres (CHB group), and a third group of people who visited primary-care centres for any reason (reference group). The study used time-location sampling , in which healthcare facilities were randomly selected from three exhaustive lists of primary-care centres (including primary-care centres for vulnerable populations), HIV outpatient hospital clinics and hepatitis treatment clinics. We constructed three distinct sampling frames (one for each healthcare specialty) by each half-day that the healthcare facilities were open. All eligible patient visits were included from each healthcare facility and each half-day time interval. To construct a sample that reflected the contribution of the various types of healthcare facility found in Île-de-France, the number of individuals to include from each facility was determined according to the group’s weight within the total population of migrants from sub-Saharan Africa in the Paris metropolitan era. The data were weighted according to each individual’s probability of inclusion in the survey.
Patients were eligible if they were born in sub-Saharan Africa, were citizens of a sub-Saharan African country at birth, were between 18 and 59 years old, and had not been diagnosed with HIV or hepatitis B (for the primary-care group) or with HIV infection or CHB (the other two groups) for at least 3 months. Recruitment occurred at the healthcare facilities. Physicians asked their eligible patients to participate and acquired their written consent.
A trained interviewer administered a face-to-face standardized life-event history questionnaire to each participant. Information collected included sociodemographic characteristics, conditions of migration and life in France, relational, sexual, and reproductive histories, and healthcare pathways that included HIV and hepatitis B virus (HBV) testing, healthcare insurance coverage, and engagement in care. Each parameter of interest was documented year to year from birth until the time of data collection. To collect retrospectively this life-event information, we used the life history calendars or “Ageven” sheet (also known as life event or life grid calendars). This tool has been shown to be effective in reducing recall bias and improving data quality in retrospective studies by providing a graphical time line that helps participants to anchor their responses in relation to different life stages and events.[39–42]
Clinical and laboratory information was documented from medical records. All information was anonymously collected.
The complete survey protocol is registered and available on Clinicaltrials.gov (NCT02566148 https://clinicaltrials.gov/ct2/show/NCT02566148). Other aspects of the study have already been presented elsewhere [43, 44].
The Advisory Committee on Data Collection in Health Research (CCTIRS) and the French Data Protection Authority (CNIL) approved the study protocol (CD-2011-484 approval on 7 December 2011). All information was anonymously collected.
To take into account difficulties in participating in the survey due to poor or no knowledge of the French language, the patient questionnaire was available in French or English, and, by appointment, an interpreter could be made available to conduct the interview in an African language spoken by the respondent.
Outcomes and variables of interest
For each year between the arrival in France and the year of data collection, HIC was documented. The first outcome was the delay of acquisition of first HIC since arrival in France. HIC was defined as any type of basic HIC that lasted for at least one year without considering supplementary health insurance. The others outcome were incidence of first HIC interruption after obtaining it and basic HIC at the time of the study (HI, UHC, SMA or none).
The fixed covariates for the analysis of the factors associated with the acquisition delay included the period of arrival, the age, the level of education, place of birth and the reported reasons for migration. Living conditions in France were documented for each year between arrival and the year of data collection through several time-dependent variables: permit of residence, housing situation, economic resources, and activity. Medical conditions including pregnancy, hospitalization, HIV and/or CHB diagnosis were dated and treated as time-dependent variables.
The analysis focused on people who arrived in France after 1980, who have been in France at time of interview for at least 2 years, aged over 18 on arrival and without missing data in the model variables. Persons who arrived before 1980 or who were under 18 years of age on arrival were not included. Persons who arrived in the previous year did not allow for a satisfactory analysis of the factors related to time. The database and analysis file for reproducing this analysis is available in supporting information (S1 Table and S2 Text)
Sociodemographic characteristics, including the main reasons for coming to France and the hardships experienced in France were compared between groups with a design-based [chi]2 test to compare proportions. Medians of duration were compared with non-parametric equality-of-medians tests.
Characteristics associated with the acquisition of HIC each year since the time of arrival in France were identified using mixed-effect logistic regression models. Models included both fixed and time-dependent covariates and were systematically adjusted for time since arrival in France.
Given the retrospective nature of the data and the heterogeneity regarding the time since arrival in France, migrants with a delayed access to HIC may have been particularly underrepresented among those who arrived within the most recent period. To assess possible bias, an additional analysis was performed in a database restricted to participants who had been in France for at least 3 years at the time of interview.
In the same way, we analysed factors associated with the loss over time of this first HIC among men and women in the 4 years after it was obtained.
Data were weighted according to each individual’s probability of inclusion in the survey and the weights were applied to all percentages. All analyses were stratified by sex due to differentiated migratory patterns and exchanges with the healthcare system.
All analyses were performed in Stata SE 13.1 (Stata Corporation, College Station, TX, USA).
A total of 1184 (reference group), 1829 (HIV) and 1169 (CHB) individuals met the eligibility criteria, among which 124, 141 and 25, respectively, were not offered participation by their physicians due to health problems or cognitive impairment. Eventually, 763 migrants in the reference group, 926 migrants with HIV, and 778 migrants with CHB agreed to participate. A total of 552 subjects were excluded for different reasons: 76 people arrived in France before 1980, 81 had been in France for less than a year, 210 were under the age of 18 at the time of their arrival, and 185 were excluded because of missing data in the variables. Consequently, a total of 1008 men and 907 women were included in the analysis: 547 in the reference group, 749 in the HIV group and 619 in the CHB group.
The sociodemographic characteristics of the participants are described in Table 1. Women accounted for 55.6% of the reference group, 62.4% of the HIV group, and 26.8% of the CHB group. The median age at arrival was 29 years in the reference group for both sexes. Men and women in the HIV group arrived when they were older. Most came from Western and Central Africa. Men most often reported coming to France to seek work and women reported that they came for family unification. The median duration of residence in France was 9 years [IQR: 2–15] for men and women in the reference group. Absences of residency permits, of personal housing, or of resources on arrival in France were frequent. The absence of a residency permit on arrival was more common in the HIV or CHB groups (Table 1).
Delay to acquisition of first HIC since arrival in France
The proportion of participants with HIC is presented year to year after arriving in France in Fig 1. HIC was obtained the year of arrival in France in median (IQR [0–1]) with no difference across groups. Among men, 55.3% had acquired an HIC the first year after arrival. This percentage rises to 74.6% the second year and 80.9% the third year after arrival in France; these figures were 63.4%, 80.2% and 86.0%, respectively, for women.
Factors associated with acquisition of HIC year to year after arrival in France
In the univariate analysis, women acquired HIC more quickly than men (odds ratio = 1.35, 95% confidence interval [1.13–1.61]). No difference in the access to HIC was observed between groups (OR = 1.10 [0.88–1.37] for HIV Group and OR = 1.11 [0.89–1.38] for CHB group; reference = Ref. group).
Among men, men who arrived after 2000 acquired HIC faster than those who had arrived earlier (Table 2). Men were more likely to acquire HIC during the year of hospitalization and if concerned, once they were diagnosed with HIV or CHB.
Conversely, men were less likely to obtain HIC during years without a residency permit and during years without resources.
In the multivariate analysis, characteristics that were significantly associated with a faster access to HIC were the arrival in France after the year 2000 (adjusted OR = 1.57 [1.20–2.06]) and HIV or CHB diagnosis (aOR = 1.72 [1.10–2.69] and 3.17 [2.17–4.64]). Characteristics associated with a delayed access to HIC were the absence of a residency permit (aOR = 0.36 [0.18–0.72]) and the absence of resources (aOR = 0.52 [0.29–0.96]).
Among women, the same associations were observed with arrival times after 2000, hospitalization, being diagnosed with HIV or CHB and lack of a residency permit (Table 2). In addition, women were more likely to have acquired HIC when they had a secondary level of education or higher at arrival. Furthermore, women were more likely to acquire HIC during the year of a pregnancy and during the years that they were students.
In the multivariate analysis, characteristics that were significantly associated with a faster access to HIC were arrival in France after the year 2000 (aOR = 1.54 [1.12–2.12]), secondary level of education at arrival (aOR = 1.65 [1.21–2.26]), French nationality (aOR = 4.84 [1.23–19.13]), years of school (aOR = 12.47 [5.17–30.07]), year of a pregnancy (aOR = 2.04 [1.35–3.07]) and HIV or CHB diagnosis if concerned (aOR = 2.75 [1.77–4.25] and 2.63 [1.42–4.87]]). The only characteristic associated with a delayed access to HIC was the absence of a residency permit (aOR = 0.44 [0.24–0.80]).
When the same analysis was performed on the restricted database (first 3 years after the arrival in France in people who had arrived more than 3 years ago, N = 1736), the period effect was still significant. Participants who arrived after the year 2000 acquired HIC more rapidly than participants who had arrived before the year 2000 (adjusted OR = 1.57 [1.12–2.20] for men and 1.94 [1.38–2.72] for women, detailed results not shown and available on request).
Four years after obtaining their first HIC, 7% of men and 3% of women had lost their HIC for more than a year (Fig 2).
Factors associated with HIC interruption year to year in the 4 years after obtaining it among men and women are presented in Table 3. In the univariate analysis, men and women without a residency permit were more likely to have lost HIC. Men who came to France because of a medical reason, men diagnosed with HIV and women under 25 years of age on arrival in France were less at risk of losing their HIC.
In the multivariate analysis, the only characteristic that was significantly associated with interruption in HIC was the lack of a residency permit for both men and women (aOR = 4.51 [2.17–9.37] and 4.41 [1.50–12.94], respectively). Women under 25 years of age on arrival in France lost their HIC less often (aOR = 0.14 [0.03–0.64]).
Of the 84 participants who lost health insurance coverage in the four years after obtaining it, 62% (N = 49) did not have a residency permit during the year of lapsed HIC. Among them, 42% (N = 22) previously had a residency permit and had lost it.
HIC at the time of the study
At the time of the survey, most African migrants had basic health insurance coverage (from 88.5 to 98.3% depending on the group and sex), most often the Health Insurance (Table 4). The Universal Health insurance Coverage (UHC) was often used (from 17.7 to 24.9%). The State Medical Assistance (SMA) was more frequent in the CHB group (24.0% of men and 21,9% of women) and among men in the reference group (13.6%).
In the reference group, 11.4% of men and 5.8% of women were uninsured (p = 0.05). This proportion was less frequent in HIV and CHB groups in both sexes (p<0.01). Uninsured participants arrived in France more recently (in median 2 years before vs 10 years for others, p<0.001) and were more often without resident permit (72.2% vs 15.7% of those with a health insurance coverage, p<0.001).
The PARCOURS survey provides original life-event data on documented and undocumented migrants living in France. This study is the first to have evaluated access to Health Insurance Coverage (HIC) among migrants year to year after their arrival in Europe. It shows that migrants from sub-Saharan Africa quickly gain access to HIC after their arrival, especially where they are in a health need. Nevertheless, this access is impaired by administrative and social insecurities.
For most migrants, access to HIC occurs in the first year after arrival in France. This finding emphasizes the positive role played by the existence of French regulations that allow health coverage for all citizens, including undocumented migrants. A comparative study of regulation regarding access to health care for undocumented migrants in European Union had placed France among the countries where access was the highest . Migrants who arrived after the year 2000 were more likely to have acquired HIC early. In France, this could be related to the implementation of the UHC for unemployed persons, including asylum seekers, and of the SMA for undocumented migrants in 1999 . Previously, these people could not benefit from Health Insurance system but only from incomplete social assistance granted by local authorities.
Despite this apparent good access, access to HIC for migrants is not always effective and requires knowledge of the French system and social assistance for access [20, 26, 29–31]. Majority of people who have recently arrived in France are not informed of their rights and existing HIC for undocumented migrants. In the Doctors of the World medical centres, only 14.2% of people who can theoretically benefit from health cover have open rights . They could also be afraid to interact with the institutions for fear to be arrested and held in detention. Among the consultants without residence permit, 35% declare to limit their movements for fear of being arrested and nearly one in four missed an address to access the rights . According to the Platform for International Cooperation on Undocumented Migrants and NGOs, thousands of undocumented migrants in France do not have the SMA coverage to which they are entitled [12, 27, 29, 30, 46]. The main reasons cited include uneven interpretation and implementation of the law across the different social security desks, undocumented migrants’ lack of awareness of the law, lack of acceptable identification documents or adequate evidence regarding residency requirements, language barriers and the fear of being arrested. The defender of rights, that is an independent constitutional authority, has also documented many barriers to rights in France . It noted, in particular, that social security desks sometimes require excessively restrictive entitlement conditions and request for unjustified documents. Institutional barriers to access have also been reported by French NGOs [29, 47]. These practices can thus be interpreted as a way of limiting the goals of the law. One of the reasons put forward by the desks for this practice is the fight against fraud. These administrative practices and abuses are variable in the territory and could be corrected through training and control.
As described before, newly arrived migrants often go through an extended period with hardships (lack of residency permit, economic resources, and housing) in France [4, 43]. Half of the women did not obtain their first valid, one-year residency permit until their third year in France, and half of men obtained this permit in their fourth year. When they obtain a residency permit, it is often a temporary permit that could be not renewed the year after. The Parcours study shows that the absence of a residency permit delayed the acquisition of HIC and was the main reason for HIC lapse. Undocumented migrants cannot benefit SMA in the first three months after their arrival in France and do not always access their rights beyond as has been described above. It is also important to note that the major French surveys addressing the issue of access to care systematically exclude undocumented migrants because of research legislation. This results shows the effect of the management of residence permits with delays and interruptions linked to the immigration policy. The lack of financial resources is also an obstacle to access HIC in men, once again emphasizing the weight of social and administrative insecurity in the access to care. Thus, despite the introduction of UHC and SMA for unemployed and undocumented migrants residing in France, illegal stay and financial hardship remain barriers to access to care.
During this hardship period, health is not a priority and access to the legal rights for medical assistance are often restricted to situations where there is an acute health concern and/or severe illness. Thus, contacts within the health care system, particularly at the time of diagnosis or complication related to HIV or CHB infections, pregnancy and hospitalization, promote health coverage. Due to a need for care, contacts within the health system facilitate access to social assistance and therefore make effective the health coverage rights provided by law. Furthermore, HIV diagnosis allows applying for a residency permit for health reasons. This may play a role in better access to HIC. In addition, there is no restriction to access to care in the case of pregnancy in France.
Among women, the level of education and current student status appear to be factors favouring HIC. This trend was described elsewhere and particularly in another large French study, where education and incomes appear to be the most important drivers of inequalities between French and immigrant populations in the propensity to access a medical specialist [20, 48].
The lack of basic health insurance coverage at the time of the study is more frequent in the reference group, among participants recently arrived and without resident permit. This confirms that despite the right to State Medical Assistance for undocumented migrants in France, some do not apply.
This study is limited by focusing on patients who are engaged in care. The distribution of Health Insurance Coverage for migrants in care may be different from that of persons not in care. Additionally, our findings may not be generalized to all HIV or CHB patients and care settings since it was conducted only in the Paris metropolitan area. However, 60% of sub Saharan migrants in France live in the Paris area and our sample is highly diversified, with patients having a variety of demographic and clinical characteristics.
In conclusion, the French social security system provides quick access to Health Insurance Coverage for the majority of immigrants arriving in France. This access is facilitated by the existence of the Health Insurance and, since 2000, by the existence of the Universal Health insurance Coverage and the State Medical Assistance. However, despite a system built to facilitate access to care for all, including undocumented migrants, socioeconomic and residency permit insecurity remain as barriers to full access. At the time of questioning of the French social model in the context of the increasing arrival of refugees, vigilance is essential to continue to secure their access to HIC, which is a condition for access to care. In particular, it is a priority to maintain the State Medical Assistance and the complementary Universal Health insurance Coverage, or better to merge it into the Health Insurance. This is all the more important as the benefit of the UHC also concerns, beyond migrants, all people in precarious situations in France. It is also important to develop actions to facilitate access to rights and care for newly arrived migrants. This is of particular interest for migrants living with HIV or CHB to improve early diagnosis, linkage to and retention in care. This is in line with the individual and public health benefits associated with HIV care and treatment: improved health outcomes and reductions in transmission risks. It is also essential to homogenize European policies to achieve the United Nations goal of universal health coverage.
The authors would like to thank all the people who participated in the study, the RAAC-Sida, COMEDE, FORIM and SOS hepatitis associations for their support in preparing and conducting the survey, Géraldine Vivier, Eva Lelièvre (INED) and Anne Gervais (AP-HP) for their support in preparing the questionnaire, A Guillaume for the communication tools, ClinSearch and Ipsos for data collection, Pierre Chauvin for the discussion of the results, and staff at all participating centres.
Participating centres and investigators:
HIV group: Hôpital intercommunal de Créteil, service de Médecine Interne (I Delacroix, B El Harrar V Garrait, L Richier); CHU le Kremlin Bicêtre, service de Médecine Interne (K Bourdic, M Duracinski, C Goujard, Y Quertainmont, D Peretti); Hôpital Delafontaine, service de Maladies Infectieuses (MA Khuong, J Krause, M Poupard, B Taverne, G Tran Van); Hôpital Tenon, service de Maladies Infectieuses et Tropicales (A Adda Lievin, P Bonnard, H Cordel, MG Lebrette, FX Lescure, P Thibault, N Velazquez, JP Vincensini); CHU Lariboisière, service de Médecine Interne A (JF Bergmann, E Badsi, J Cervoni, M Diemer, A Durel, P Sellier, M Bendenoun, JD Magnier); CHU Saint-Antoine, service de Maladies Infectieuses et Tropicale (E Bui, J Tredup, P Campa, N Desplanque, M Sebire); Hôpital Saint-Louis, services de Maladies Infectieuses et Tropicale et d’Immunologie Clinique (D Ponscarme, N Colin de Verdière, V de Lastours, J Gouguel, C Gatey, C Lascoux-Combe, V Garrait, F Taieb, N De Castro, L Gérard); Hôpital Bichat Claude Bernard, service de Maladies Infectieuses, VIH, et Tropicales (G Pahlavan, B Phung, F L’Heriteau, A Dia, A Lepretre, G Morau, C Rioux, V Joly, Y Yazdanpanah, S Legac); Hôpital René Dubos, service de Médecine Interne Dermatologie (L Blum, M Deschaud); Hôpital Européen George Pompidou, service d’Immunologie Clinique (M Buisson, P Kousignian, C Minozzi, M Karmochkine, D Batisse, J Pavie, M Eliaczewicz, L Weiss, G Gonzalez, P Castiel, I Pierre, M Beumont, D Jayle, J Derouinau, M Manea, E Bourzam); CHU Avicenne, service de Maladies Infectieuses et Tropicales (S Abgral, S Mattioni, R Barruet, N Sayre, O Bouchaud, M Tatay, M Gousseff, F Mechai, T Kandel, P Honoré, M Coupard); CHU Cochin Tannier, service d’unité Fonctionnelle de Pathologie Infectieuse (F Bani-Sadr, L Belarbi, G Spiridon, T Tahi, H Mehawej, D Salmon, B Silbermann, A Calboreanu, P Loulergue, H Bouchez, V Le Baut, MP Pietri); Centre hospitalier de Gonesse, service de Médecine Interne (D Trois-Vallets, V Favret); Hôtel Dieu, Centre de Diagnostic et de Thérapeutique (JP Viard, A Sobel, J Gilquin, A Cros, A Maignan); CHI Poissy/Saint-Germain-en-Laye, service de Maladies Infectieuses et Tropicales (Y Welker, H Masson, B Montoya, JL Ecobichon); CH de Lagny Marne la Vallée, service de maladies infectieuses (E Froguel, P Simon, MS Nguessan, S Tassi); Nouveau Centre Hospitalier Sud Francilien, service d’Hématologie Clinique (A Devidas, L Gerard, H Touahri); CHI Robert Ballanger, service de Médecine Interne et Maladies Infectieuses (JL Delassus, MA Bouldouyre, V Favret); Hôpital Intercommunal André Grégoire, service de Médecine Interne (C Winter); CHU La Pitié-Salpetrière, services de Médecine Interne 1 et de Maladies Infectieuses et Tropicales (S Pelletier, MC Samba, S Herson, A Simon, M Bonmarchand, N Amirat, N Smail, S Seang, H Stitou, L Schneider, R Tubiana, L Epelboin, MA Valantin, C Katlama, S Ben Abdallah, P Bourse, Y Dudoit, C Blanc); Centre Médical Institut Pasteur, consultations spécialisées (C Charlier-Woerther, O Lortholary, PH Consigny, A Gergely, M Shoai-Tehrani, G Cessot, C Duvivier, F Touam, K Benhadj); CMC de Bligny, service de Maladies Infectieuses et VIH (H Ait Mohand, E Klement, P Chardon).
Chronic Hepatitis B group: Hôpital Beaujon, service d’Hépatologie (A Pumpo, T Asselah, N Guilly, N Boyer, F Mouri, C Castelnaud, M Pouteau); Hôpital Pitié-Salpêtrière, service d’Hépato-Gastroentérologie et de Médecine Interne (T Poynard, Y Benhamou, G Bonyhay, P Lebray, J Massard, J Moussali, V Ratziu, M Rudler, D Thabut, R Pais, E Luckina, A Simon, MC Samba, S Pelletier, N Smail); Hôpital Paul Brousse, Centre Hépato-Biliaire (JC Duclos Vallée, D Samuel, A Coilly); CHU Henri Mondor, service d’Hépatologie (F Roudot-Thoraval, C Hezode, E Lopes); Hôpital Jean Verdier, service d’Hépato-Gastroentérologie (V Bourcier, N Ganne, P Nahon, J Cohelo, JC Trinchet, G Gnkontchou, V Grando, S Brulé); Hôpital Cochin, unité d’Hépatologie (P Sogni, H Fontaine, V Mallet, S Tripon, A Vallet Pichard, S Pol, M Corouge, M Benazra, A Noble, L Bousquet); Hôpital Saint-Antoine, service d’Hépato-Gastroentérologie (D Mohand, L Serfaty, N Carbonell, C Corpechot, M Lequoy, H Mathiex-Fortunet, A Pascale, O Rosmorduc, O Chazouillères, S Mezhoud, T Andreani, H Regnault, A Poujol-Robert, F Benjelloun); Hôpital Gouin, service d’Hépato-Gastroentérologie (S Levy); Hôpital Avicenne, services de Médecine Interne et de Maladies Infectieuses (D Roulot, U Warzocha, C Cambonie, O Bouchaud, F Mechai, M Goussef, N Vignier, T Kandel, P Honore); CH de Lagny Marne La Vallée, service de Gastroentérologie (F Harnois, G Macaigne, K Fernandes); Hôpital Lariboisière, services de Médecine Interne et d’Hépato-Gastroentérologie (JF Bergmann, P Sellier, M Bendenoun, JD Magnier, V Ozenne); Hôpital Tenon, services d’Hépato-Gastroentérologie et de Maladies Infectieuses (D Ancel, I Popa-Gregoriou, F Amiot, A Garioud, JD Grangé, D Chaslin-Ferbus, S Gil-Diez, P Bonnard, MG Lebrette, H Cordel, FX Lescure, JP Vincensini, A Adda Lievin, P Thibault, N Velazquez); Centre Hospitalier Intercommunal de Créteil, service d’Hépato-Gastroentérologie (S Barge, I Rosa, L Costes, L Richier); Réseau ARES 92 (A Seif, C Chandemerle, M Lalande, T Mazars); Réseau Paris Nord (JP Aubert, O Taulera); Centre de santé du Comede (I Alix, F Fleury, O Lefebvre, P Revault, M Petruzzi, C Menard).
Référence group: Centre municipal de santé Gentilly (JJ Bourcart); PASS Hôpital Saint-Louis (C Georges, M Andlauer, Y Girardeau, F Tapié de Celeyran, P Bordon, N Dardel, D Levy, O Taulera, ML Pintir Rageau, S Dehaudt); PASS Hôpital Lariboisière (C Aparicio, U Loeung, C Toussaint); PASS Hôpital Saint-Antoine (V Vasseur, A Andel, O Cha, P Xu, V Sivalingam, I Hiesse, S Ouaret, L Zahzam, E Bui); PASS hôpital La Pitié-Salpêtrière (E Baut, MA Temple, A Gillet, C Leata, J Legoff); Centre médical et dentaire Henri Barbusse-Gagny (F Jardin, E Jean Baptiste); Centre d’Accueil de Soins et d’Orientation (E Corp, J Nau, B Chatelin, P Weeger, N Hervier, L Lacroze); Centre municipal de santé Colombes (L Ballonard, A. Seif); Centre médico-social COMEDE (I Alix, F Fleury, O Lefebvre, P Revault, M Petruzzi, C Menard); Centre médico-social Fresnes (Y Chahan, J Prost); Centre médico-social Livry-Gargan (D Spindler, L Rodin Zita, Nguyen, K Dambielle); Centre médico-social Ambroise Croizat Franconville (P Bourlier, P Zaidi); Centre médico-social Mai-Politzer Arcueil (F Block); Centre de santé Françoise Dolto Tremblay-en-France (N Bessah); Centre médico-social Fontenay aux roses (G Barbier, G Pilorget, N Touazi); Centre Polyvalent de Santé Aimé Césaire Bobigny (F Rouges, C Chalal); Centre médical Pierre Rouques Villejuif (L Cavanna, A Sabah, M C Charansonnet, G Ibanez); Centre de santé C.P.A.M. Choisy-le-Roi (M Lesourd); Centre municipal de santé Issy-les-Moulineaux (M Orbach-Roulière, JP Vilanova); Centre médical Elio Habib—Paris (M Smadja, E Rozenkier); Centre de santé Pierre Rouquès Le Blanc-Mesnil (C Vincent, V Bontemps, A Ngaleu, F Bensidhoum); Centre de santé Centre médico-social JA Dolidier Pierrefitte (M Gharmaoui, B Hubert-Andreani, V Vinçon, K Royer, S Vernerey-Martin, C Meunier, S Djouhri, V Ngadjeu); Centre médico-social Maurice Ténine Champigny-sur-Marne (F Villebrun, D Soletchnik, M Deroche, S Henry, M Geminel, C Tison, M Dupuy, E Balgone); Centre municipal de santé Nanterre (M Esteve, C Terra, Charles, L Rossignol, C Bismuth, G Gillemot, M Vanbana); Centre de santé Henri Barbusse Saint-Ouen (M Djouab, G Lyon, F Ogier, J.Gelly); Centres de santé Savattero Montreuil (P Vidigal, A Gibier, A Simonnet-Richard, C Alvarez-Malgras); Dispensaire C.R.F. Boulogne Billancourt (C Dufresne, B Huault, I Cornuche); Centre municipal de Santé Louis-Fernet Sevran (H Touitou, S D’Epiro, F Michard, N Guesnier, F Siecat); Centre médico-social Haxo Paris (N Pinard, H Gaborieau); Centre médico-social Pierre Rouques Vitry-sur-Seine (A Beaupin, G Albouy, C Besacier, A Soares, J Le Breton).
The PARCOURS Study Group included A.D.L., F.L., R.D.-S., N.B., N.L. (scientific coordinators), J.P., A.R., A.G., N.V., Elise Rodary, Dolorès Pourette, Joseph Situ, Pascal Revault, Philippe Sogni, Julien Gelly, Yann Le Strat, Nicolas Razafindratsima.
- 1. Zimmerman C, Kiss L, Hossain M. Migration and health: a framework for 21st century policy-making. PLoS Med. 2011;8(5):e1001034. pmid:21629681.
- 2. UN. International migration report 2015. New York: United Nations, Departement of Economic and Asocial Affairs, Population Division., 2016 Contract No.: ST/ESA.SER.A/384.
- 3. Hanefeld J, Vearey J, Lunt N, Researchers on Migration M, Health G. A global research agenda on migration, mobility, and health. Lancet. 2017;389(10087):2358–9. pmid:28635599.
- 4. Gosselin A, Desgrées du Loü A, Lelievre E, Lert F, Dray Spira R, Lydie N, et al. How long do sub-Saharan migrants take to settle in France? Population et societies. 2016;533:1–4.
- 5. Simon J, Kiss N, Laszewska A, Mayer S. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Labour Migrants in the European Region. WHO Health Evidence Network Synthesis Reports. Copenhagen2015.
- 6. De Vito E, de Waure C, Specchia ML, Ricciardi W. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Undocumented Migrants in the European Region. WHO Health Evidence Network Synthesis Reports. Copenhagen2015.
- 7. Vazquez ML, Vargas I, Jaramillo DL, Porthe V, Lopez-Fernandez LA, Vargas H, et al. Was access to health care easy for immigrants in Spain? The perspectives of health personnel in Catalonia and Andalusia. Health policy. 2016;120(4):396–405. pmid:26898401.
- 8. Derose KP, Bahney BW, Lurie N, Escarce JJ. Review: immigrants and health care access, quality, and cost. Med Care Res Rev. 2009;66(4):355–408. pmid:19179539.
- 9. Magalhaes L, Carrasco C, Gastaldo D. Undocumented migrants in Canada: a scope literature review on health, access to services, and working conditions. J Immigr Minor Health. 2010;12(1):132–51. pmid:19657739.
- 10. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2013;381(9873):1235–45. pmid:23541058.
- 11. Scheppers E, van Dongen E, Dekker J, Geertzen J, Dekker J. Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract. 2006;23(3):325–48. pmid:16476700.
- 12. Gray BH, van Ginneken E. Health care for undocumented migrants: European approaches. Issue Brief (Commonw Fund). 2012;33:1–12. pmid:23289160.
- 13. Dourgnon P, Jusot F, Silva J, Sermet C. Immigrants’ access to ambulatory care in France. Questions d’économie de la santé. 2009;146.
- 14. Biswas D, Kristiansen M, Krasnik A, Norredam M. Access to healthcare and alternative health-seeking strategies among undocumented migrants in Denmark. BMC Public Health. 2011;11:560. pmid:21752296.
- 15. Deville W, Greacen T, Bogic M, Dauvrin M, Dias S, Gaddini A, et al. Health care for immigrants in Europe: is there still consensus among country experts about principles of good practice? A Delphi study. BMC Public Health. 2011;11:699. pmid:21914194.
- 16. Jensen NK, Norredam M, Draebel T, Bogic M, Priebe S, Krasnik A. Providing medical care for undocumented migrants in Denmark: what are the challenges for health professionals? BMC Health Serv Res. 2011;11:154. pmid:21711562.
- 17. Woodward A, Howard N, Wolffers I. Health and access to care for undocumented migrants living in the European Union: a scoping review. Health Policy Plan. 2014;29(7):818–30. pmid:23955607.
- 18. Agudelo-Suarez AA, Gil-Gonzalez D, Vives-Cases C, Love JG, Wimpenny P, Ronda-Perez E. A metasynthesis of qualitative studies regarding opinions and perceptions about barriers and determinants of health services’ accessibility in economic migrants. BMC Health Serv Res. 2012;12:461. pmid:23245431.
- 19. Maruthappu M, Watkins J, Noor AM, Williams C, Ali R, Sullivan R, et al. Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysis. Lancet. 2016. pmid:27236345.
- 20. Berchet C. [Health care utilisation in France: an analysis of the main drivers of health care use inequalities related to migration]. Rev Epidemiol Sante Publique. 2013;61 Suppl 2:S69–79. pmid:23684103.
- 21. Sommers BD, Gunja MZ, Finegold K, Musco T. Changes in Self-reported Insurance Coverage, Access to Care, and Health Under the Affordable Care Act. JAMA. 2015;314(4):366–74. pmid:26219054.
- 22. Lillie-Blanton M, Hoffman C. The role of health insurance coverage in reducing racial/ethnic disparities in health care. Health affairs. 2005;24(2):398–408. pmid:15757923.
- 23. WHO. Global health and foreign policy. 2012.
- 24. UN. Transforming our world: the 2030 Agenda for Sustainable Development. In: United Nations, editor. New York2015.
- 25. WHO. Resolution 61.17: health of migrants. Geneva: World Health Assembly, 2008.
- 26. Nay O, Bejean S, Benamouzig D, Bergeron H, Castel P, Ventelou B. Achieving universal health coverage in France: policy reforms and the challenge of inequalities. Lancet. 2016. pmid:27145707.
- 27. Andre J-M, Azzedine F. Access to healthcare for undocumented migrants in France: a critical examination of State Medical Assistance. Public Health Reviews. 2016;37(5).
- 28. Platform for International Cooperation on Undocumented Migrants. Access to health care for undocumented migrants in Europe. PICUM, 2007.
- 29. Chappuis M, Tomasino A, Didier E. Observatoire de l’accès aux droits et aux soins de la mission France de Médecin du Monde. Rapport 2015. [Observatory of access to rights and care of the France mission of Médecin du Monde. Report 2015.]. Médecin du Monde et Observatoire régional de la santé de Midi-Pyrénées, 2016.
- 30. Le défenseur des droits. Les droits fondamentaux des étrangers en France. [The fundamental rights of foreigners in France]. Paris: Le défenseur des droits, 2016.
- 31. Comede. Rapport 2017 du Comede. Activité 2016 [2017 Report of the Comede. Activity 2016]. Le Kremlin Bicêtre: Comede, 2017.
- 32. Le Vu S, Le Strat Y, Barin F, Pillonel J, Cazein F, Bousquet V, et al. Population-based HIV-1 incidence in France, 2003–08: a modelling analysis. Lancet Infect Dis. 2010;10(10):682–7. pmid:20832367.
- 33. Meffre C, Le Strat Y, Delarocque-Astagneau E, Antona D, Desenclos JC. Prévalence des hépatites B et C en France en 2004 [Prevalence of hepatitis B and C in France in 2004]. Institut de veille sanitaire, 2007.
- 34. Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2009;48(2):248–56. pmid:19072715.
- 35. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. pmid:21767103.
- 36. Calvez M, Semaille C, Fierro F, Laporte A. [Delayed access to care, precariousness and vulnerability of HIV-positive women]. Med Sci (Paris). 2008;24 Spec No 2:144–50. pmid:18681131.
- 37. McManus KA, Rhodes A, Bailey S, Yerkes L, Engelhard CL, Ingersoll KS, et al. Affordable Care Act Qualified Health Plan Coverage: Association With Improved HIV Viral Suppression for AIDS Drug Assistance Program Clients in a Medicaid Nonexpansion State. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016;63(3):396–403. pmid:27143661.
- 38. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19 Suppl 2:S67–72. pmid:15930843.
- 39. Antoine P, Bry X, Diouf PD. La fiche "AGEVEN": un outil pour la collecte des données rétrospectives [The "AGEVEN" sheet: a tool for retrospective data collection]. Techniques d’Enquête. 1987;13(2):173–81.
- 40. Glasner T, van der Vaart W. Applications of calendar instruments in social surveys: a review. Qual Quant. 2009;43(3):333–49. pmid:20046840.
- 41. Belli RF. The structure of autobiographical memory and the event history calendar: potential improvements in the quality of retrospective reports in surveys. Memory. 1998;6(4):383–406. pmid:9829098.
- 42. Vanhoutte B, Nazroo J. Life-history data. Public Health Res Pract. 2016;26(3). pmid:27421342.
- 43. Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, et al. Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France. AIDS. 2016;30(4):645–56. pmid:26558722.
- 44. Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Gosselin A, Supervie V, Panjo H, et al. Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013. Euro Surveill. 2015;20(46). pmid:26607135.
- 45. Cuadra CB. Right of access to health care for undocumented migrants in EU: a comparative study of national policies. Eur J Public Health. 2012;22(2):267–71. pmid:21659389.
- 46. Duguet AM, Beviere B. Access to health care for illegal immigrants: a specific organisation in France. Eur J Health Law. 2011;18(1):27–35. pmid:21409970.
- 47. Comede. Rapport 2016 du Comede, Synthèse de l’activité 2015. [2016 Report of the Comede, Synthesis of activity 2015]. Kremlin Bicêtre: Comede, 2016.
- 48. Assaf S, Campostrini S, Di Novi C, Xu F, Gotway Crawford C. Analyzing disparity trends for health care insurance coverage among non-elderly adults in the US: evidence from the Behavioral Risk Factor Surveillance System, 1993–2009. Eur J Health Econ. 2016. pmid:27241187.